BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Tian J, Hui W, Kong W, Feng Y, Si J, Gao F. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis. Sci Rep 2021;11:4143. [PMID: 33603125 DOI: 10.1038/s41598-021-83647-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Miri AH, Kamankesh M, Llopis-lorente A, Liu C, Wacker MG, Haririan I, Asadzadeh Aghdaei H, Hamblin MR, Yadegar A, Rad-malekshahi M, Zali MR. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Front Pharmacol 2022;13:917184. [DOI: 10.3389/fphar.2022.917184] [Reference Citation Analysis]
2 Borbath I, Pape UF, Deprez PH, Bartsch DK, Caplin M, Falconi M, Garcia-Carbonero R, Grozinsky-Glasberg S, Jensen RT, Arnold R, Ruszniewski P, Toumpanakis C, Valle JW, O Toole D; Members of the Advisory Board of the European Neuroendocrine Tumor Society (ENETS). ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. J Neuroendocrinol 2022;:e13105. [PMID: 35233848 DOI: 10.1111/jne.13105] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Gu SY, Cao XJ, Feng Y, Wei QQ, Liang JQ, Xie LM, Liu YL, Feng HY, Guo XG. Identification of hub genes and signaling pathways related to gastric cells infected by Helicobacter pylori. Microb Pathog 2021;156:104932. [PMID: 33964417 DOI: 10.1016/j.micpath.2021.104932] [Reference Citation Analysis]